
Derivados de Quinazolina y Quinolina
Las quinazolinas y quinolinas son compuestos heterocíclicos nitrogenados con estructuras aromáticas que desempeñan un papel clave en la síntesis de fármacos con actividad anticancerígena, antimicrobiana y antiinflamatoria. Sus derivados presentan modificaciones estructurales que optimizan su biodisponibilidad y selectividad, lo que permite el desarrollo de nuevos principios activos para diversas aplicaciones terapéuticas. Estos compuestos se utilizan en la fabricación de APIs destinados al tratamiento de cáncer, infecciones, enfermedades neurodegenerativas y cardiovasculares. Además, los derivados de quinazolina y quinolina son esenciales en la investigación de inhibidores enzimáticos y en el diseño de moléculas bioactivas innovadoras. En CymitQuimica disponemos de derivados de quinazolina y quinolina de alta pureza para aplicaciones en síntesis química, desarrollo farmacéutico y biotecnología.
Se han encontrado 65576 productos de "Derivados de Quinazolina y Quinolina"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Dibenzazepinodione (5H-dibenzo[b,f]azepine-10,11-dione)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C14H9NO2Forma y color:Dark Orange SolidPeso molecular:223.06333Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C36H43NO6·H2OForma y color:White SolidPeso molecular:603.3196Rivaroxaban N-methylphthalamido Analog ((S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C23H24N4O6Forma y color:White Off-White SolidPeso molecular:452.16958Alcohol
CAS:Ethyl alcohol, undenatured, of an alcoholic strength by volume of 80 percent vol. or higher, for nonbeverage purposes, excluding for fuel useFórmula:C2H6OForma y color:Clear Colorless LiquidPeso molecular:46.07Desmethoxyomeprazole
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C16H17N3O2SForma y color:Light Brown Grey Yellow PowderPeso molecular:315.10415Clioquinol Related Compound B (5,7-Dichloroquinolin-8-ol)
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFórmula:C9H5Cl2NOForma y color:White Off-White PowderPeso molecular:212.97482Duloxetine Related Compound H ((S)-4-{Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino}-4-oxobutanoic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H23NO4SForma y color:White Crystalline PowderPeso molecular:397.13478Carvedilol Bisalkylpyrocatechol derivative (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C40H42N4O6Forma y color:Off-White Light Brown SolidPeso molecular:674.31044Clioquinol
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFórmula:C9H5ClINOForma y color:PowderPeso molecular:304.91044Sodium Starch Glycolate Type A
CAS:Modified starches, nesoiFórmula:(C2H4O3)x·(Na)xForma y color:White Off-White PowderPeso molecular:515.6862Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C25H37NO4Forma y color:Off-White Crystalline PowderPeso molecular:415.27226Hexyl Methanesulfonate
CAS:Hydrocarbon derivatives containing only sulfo groups, their salts andestersFórmula:C7H16O3SForma y color:Clear Yellow LiquidPeso molecular:180.08202Norepinephrine Bitartrate
CAS:Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFórmula:C8H11NO3·C4H6O6·H2OForma y color:White Light Grey Crystalline PowderPeso molecular:337.1009Rivaroxaban Amine ((S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H17N3O4·HClForma y color:Off-White SolidPeso molecular:327.09858Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C12H14FN·HClForma y color:White PowderPeso molecular:191.11103Atazanavir Formyl Analog (methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-formamido-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C37H50N6O6Forma y color:Off-White SolidPeso molecular:674.37918Tazarotene Related Compound B (Ethyl 6-chloronicotinate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C8H8ClNO2Forma y color:Colorless Material Melts At 30⁰ C And Becomes Liquid However The Material Is In Solid State At Below 25⁰CPeso molecular:185.02436Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C21H21N3O5Forma y color:White Off-White SolidPeso molecular:395.14812Methoxyethyl Phenol
CAS:Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFórmula:C9H12O2Forma y color:White PowderPeso molecular:152.083735-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C5H5NO3Forma y color:White SolidPeso molecular:127.02694Saxagliptin Related Compound A (Saxagliptin pyrazine analog (1aS,4S,6aR,7aS)-6-amino-4-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]-1,1a,4,6a,7,7a-hexahydro-3H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C18H25N3O2Forma y color:White Fine PowderPeso molecular:315.19468Rivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H21Cl2N3O7S2Forma y color:Off-White SolidPeso molecular:597.0198Mirabegron
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C21H24N4O2SForma y color:White Off-White Brownish Yellow Crystalline PowderPeso molecular:396.162Sorafenib Related Compound H (4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C21H16ClF3N4O3Forma y color:Pale Yellow SolidPeso molecular:464.0863Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFórmula:C23H37N7O5SForma y color:Off-White PowderPeso molecular:523.25769Naproxen Sodium
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C14H13NaO3Forma y color:White Cream PowderPeso molecular:252.07624Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H20FNO3·HClForma y color:White PowderPeso molecular:365.1194Fluvoxamine Maleamide (13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFórmula:C19H23F3N2O5Forma y color:Off-White SolidPeso molecular:416.15591Everolimus
CAS:Antibiotics nesoiFórmula:C53H83NO14Forma y color:White Yellow PowderPeso molecular:957.58136Silodosin S-Enantiomer
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C25H32F3N3O4Forma y color:White Off-White Crystalline PowderPeso molecular:495.23449Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFórmula:C9H7NO2Forma y color:White Off-White SolidPeso molecular:161.04768Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H16N2O4Forma y color:White Off-White SolidPeso molecular:264.11101Desimidazoline Sunitinib (5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C14H23N3O2Forma y color:White Off-White PowderPeso molecular:265.17903Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS:Sulfonamides, nesoiFórmula:C19H27N3O6S2Forma y color:Off-White PowderPeso molecular:457.13413Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H19N3O4SForma y color:Off-White PowderPeso molecular:361.10963Bupropion Hydrochloride Related Compound B (2-(tert-butylamino)-3'-bromopropiophenone hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H18BrNO·HClForma y color:Off-White PowderPeso molecular:319.03385Erlotinib Related Compound A (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C25H29N3O5·HClForma y color:Off-White PowderPeso molecular:451.21072Apremilast Open Ring 3-acetamide ((S)-3-acetamido-2-((1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)carbamoyl)benzoic acid)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Fórmula:C22H26N2O8SForma y color:Off-White SolidPeso molecular:478.14099N-Nitroso Bupropion Solution (1 mL ) (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS:Compounds with other nitrogen function, nesoiFórmula:C13H17ClN2O2Forma y color:LiquidPeso molecular:268.09786Deschloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-phenylpropan-1-one hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H19NO·HClForma y color:White PowderPeso molecular:241.123345-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,5-dichlorophenyl)propan-1-one hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H17Cl2NO·HClForma y color:White PowderPeso molecular:309.0454Fluconazole
CAS:Anti-infective agents, nesoiFórmula:C13H12F2N6OForma y color:White Off-White PowderPeso molecular:306.10407Atazanavir Dipeptide Analog (methyl ((5S,8S,13S,14S,17S)-14-benzyl-5,8-di-tert-butyl-13-hydroxy-18,18-dimethyl-3,6,9,16-tetraoxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,10,11,15-pentaazanonadecan-17-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C44H63N7O8Forma y color:SolidPeso molecular:817.47381Clozapine Benzoyl Methylpiperazine Analog (1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C18H21ClN4OForma y color:Beige PowderPeso molecular:344.14039Desacetyl Apremilast ((S)-4-Amino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Fórmula:C20H22N2O6SForma y color:Yellow PowderPeso molecular:418.11986Rivaroxaban phthalimido ethyl ester analog ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C29H26ClN3O8SForma y color:White Off-White SolidPeso molecular:611.11291Dofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)
CAS:Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFórmula:C17H23N3OForma y color:Off-White PowderPeso molecular:285.18411Fluticasone Propionate Related Compound D (6α,9-Difluoro-11β-hydroxy-16α-methyl-17-[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate)
CAS:Halogenated derivatives of adrenal cortical hormonesFórmula:C25H32F2O5SForma y color:White Off-White PowderPeso molecular:482.19385Dasatinib Related Compound B (N-(2-Chloro-6-methylphenyl)-2-{[2-methyl-6-(piperazin-1-yl)pyrimidin-4-yl]amino}thiazole-5-carboxamide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C20H22ClN7OSForma y color:White Off-White PowderPeso molecular:443.12951Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS:<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Fórmula:C21H21N3O5Forma y color:White Off-White SolidPeso molecular:395.14812

